Home › Inflammatory Bowel Disease › Connecticut › New Haven
Inflammatory Bowel Disease clinical trials in New Haven, CT
3 studies for Inflammatory Bowel Disease are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Medical Research Center of Connecticut, LLC, Hamden · 6 mi away
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RecruitingObservational study
- Yale University School of Medicine, New Haven
Inflammatory Bowel Disease trials in other cities
- New York City, NY18 studies
- Boston, MA15 studies
- Seattle, WA9 studies
- Miami, FL9 studies
- Houston, TX8 studies
- Orlando, FL8 studies
- Atlanta, GA8 studies
- Durham, NC8 studies
- Washington, DC7 studies
- St. Louis, MO7 studies
- Philadelphia, PA7 studies
- Cincinnati, OH7 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Opioid Overdose18 studies
- Alcohol Use Disorder (AUD)17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.